<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Bootstrap Agency Page Template</title>
    <!-- Bootstrap -->
    <link href="css/bootstrap-4.4.1.css" rel="stylesheet">
  </head>
  <body>
    <nav class="navbar navbar-expand-lg navbar-dark bg-dark py-4">
      <a class="navbar-brand py-4" href="home.html"><img src="images/logo_bootstrap_transp.png" alt="S1P Therapeutics - Home" width="204" height="30"></a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button>
      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav me-auto">
        <ul class="navbar-nav me-auto">
		   <li class="nav-item"> <a class="nav-link" href="home.html">HOME</a> </li>
          <li class="nav-item"> <a class="nav-link" href="about.html">ABOUT US</a> </li>
          <li class="nav-item active"> <a class="nav-link" href="science.html">SCIENCE</a> </li>
		  <li class="nav-item"> <a class="nav-link" href="news.html">NEWS</a> </li>
		  <li class="nav-item"> <a class="nav-link" href="contact.html">CONTACT</a> </li>	
        </ul>
        </ul>
      </div>
  </nav>
    <section class="offset-xl-0 col-xl-11">
		  <div class="row no-gutters">

		  <div class="col align-self-center offset-xl-1 col-xl-10">
			  <br>
			  <h1>OUR APPROACH</h1>
				<p class="text-justify">Sphingosine-1-phosphate (S1P) is a chemotactic lipid that influences immune cell positioning, endothelial barrier integrity, and fibrosis. S1P concentration gradients are necessary for proper egress of lymphocytes from the thymus and secondary lymphoid tissues. Extracellular S1P acts as a ligand to G-protein coupled receptors (S1P1-5). In particular, binding to S1P1 results in receptor internalization and blocks lymphocyte egress from lymph nodes to efferent lymph. This trafficking is interdicted by S1P receptor modulators, which are clinically approved drugs for remitting relapsing multiple sclerosis and ulcerative colitis. Unfortunately, first-dose bradycardia is an adverse effect of the S1P1 receptor agonist drug class. An alternate therapeutic strategy is to re-shape the S1P gradients by selective blockade of S1P transport via Spns2. S1P Therapeutics has the only known proprietary inhibitors of Spns2 that are being developed for the potential treatment of inflammatory and fibrotic diseases.</p>
			  </div>
		</div>
		
		<div class="row no-gutters offset-xl-1 col-xl-10">
      		<div class="col align-self-center text-center">
          		<br>	
				<img src="images/biorender_v1_transp.png" alt="S1P therapeutics logo" class="img-fluid">
			</div>
      </div>
		<br>
	  </section>
    <footer class="text-center bg-dark">
      <div class="container">
        <div class="row">
          <div class="col-12" style="color:white;">
            <p>Copyright Â© S1P Therapeutics. All rights reserved.</p>
          </div>
        </div>
      </div>
    </footer>
	    </body>
    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) --> 
    <script src="js/jquery-3.4.1.min.js"></script> 
    <!-- Include all compiled plugins (below), or include individual files as needed --> 
    <script src="js/popper.min.js"></script> 
    <script src="js/bootstrap-4.4.1.js"></script>
</html>